Acquired type 2A von Willebrand disease in chronic myelocytic leukemia

Hematopathology and Molecular Hematology

Volumn 10, Issue 3, 1996, Pages 123-133

  Mohri, Hiroshi ^a   Tanabe, Juichi ^a   Yamazaki, Etsuko ^a   Yoshida, Michihiko ^a   Harano, Hiroshi ^a   Matsuzaki, Michio ^a   Motomura, T Shigeki ^a   Okubo, Takao ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Acquired von Willebrand disease; CML; Inhibitor; Von Willebrand factor

Indexed keywords

BOTROCETIN; IMMUNOGLOBULIN G ANTIBODY; RISTOCETIN; STAPHYLOCOCCUS PROTEIN A; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING TENDENCY; BLEEDING TIME; CASE REPORT; CHRONIC MYELOID LEUKEMIA; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE AGGLUTINATION; VON WILLEBRAND DISEASE;

BLEEDING TIME; HUMANS; IMMUNOGLOBULIN G; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; VON WILLEBRAND DISEASE;

EID: 0029851975     PISSN: 10828893     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan P, Huffman T: Fibrinogen-independent platelet adhesion and thrombus formation of subendothelium mediated by glycoprotein Ilb/IIIa complex at high shear rate. J Clin Invest 83:288, 1989.
2. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Ando H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM: The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 87:1234, 1991.
3. Ruggeri ZM, DeMarco L, Galti L, Bader R, Montgomery RR: Platelets have more than one binding site for von Willebrand factor. J Clin Invest 72:1, 1983.
4. Mohri H, Yoshioka A, Zimmerman TS, Ruggeri ZM: Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites. J Biol Chem 264:17361, 1989.
5. Kao K-J, Pizzo S V, McKee PA: Demonstration and characterization of specific binding sites for factor VIII/ von Willebrand factor on human platelets. J Clin Invest 63:656, 1979.
6. Read MS, Shermer RW, Brinkhous KM: Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sei USA 75:4514, 1978.
7. Ginsburg D, Bowie EJW. Molecular genetics of von Willebrand disease. Blood 79:2507, 1992.
8. Brinkhous KM, Read MS, Fricke WA, Wagner RH. Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric form of factor VIII macromolecular complex. Proc Natl Acad Sei USA 80:1463, 1983.
9. Façon T, Caron C, Courtin P, Wurtz A, Deghaye M, Bauters F, Marurier C, Goundemand J: Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma. Br J Haematol 80:488, 1992.
10. Budde V, Dent JA, Berkowitz SC, Ruggeri ZM, Zimmerman TS: Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome. Blood 68:1213, 1986.
11. Richard C, Guadrado MA, Orieto M, Battle J, Lopez-Fernandez MF, Rodriguez Salazar ML, Bello C, Recio M, Santoro T, Gomez-Casares MT, Zubizarreta A: Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Hematol 35:114, 1990.
12. Ball J, Malia RG, Greaves M, Preston FE: Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with circulating inhibitor. Br J Haematol 65:95, 1987.
13. Mohri H, Noguchi T, Kodama F, Itoh A, Okubo T: Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor. Am J Clin Pathol 87:663, 1987.
14. Lopez-Fernandez MF, Martin R, Lopez-Berges C, Ramos F, Bosch N, Battle J: Further specificity characterization of von Willebrand factor inhibitors developed in two patients with severe von Willebrand disease. Blood 72:116, 1988.
15. Andrew RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Bemdt MC: Cross-linking of monomeric 39/34 kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the a-chain of membrane glycoprotein Ib on intact platelets with Bis (sulfosuccimidyl) suberate. Biochemistry 28:8326, 1989.
16. Girma J-P, Chopek M W, Titani K, Davie EW: Limited proteolysis of human vWF by Staphylococcus aureus V-8 protease: isolation and partial characterization of platelet-binding domain. Biochemistry 25:3156,1986.
17. Ey PL, Prowse SJ, Jenkin CR: Isolation of pure IgGl, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry 15:429, 1978.
18. Fujimura Y, Titani K, Usami Y, Suzuki M, Oyama R, Matsui T, Fukui H, Sugimoto M, Ruggeri ZM: Isolation and characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 30:1957, 1991.
19. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57:1140, 1981.
20. Berliner S, Niiya K, Roberts JR, Houghten RA, Ruggeri ZM: Generation and characterization of peptidespecific antibodies that inhibit von Willebrand factor binding to glycoprotein Hb-IIIa without interaction with other adhesive proteins. J Biol Chem 263:7500, 1988.
21. Kumar R, Ansell JE, Casono RT: Clinical trial of a new bleeding time device. Am J Clin Pathol 70:642,1978.
22. Mohri H: Acquired von Willebrand's disease and storage pool disease in chronic myelocytic leukemia. Am J Hematol 22:391, 1986.
23. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantitities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248, 1976.
24. Fricke WA, Brinkhous KM, Garris JB, Roberts HR: Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody. Blood 66:562, 1985.
25. Sampson BM, Greaves M, Maia RG, Preston FE. Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases. Br J Haematol 54:233, 1983.
26. Noronha PA, Hruby MA, Maurer HS: Acquired von Willebrand disease in a patient with Wilm's tumor. J Pediatr 95:997, 1979.
27. Soft GA, Green D: Autoantibody to von Willebrand factor in systemic lupus erythematosus. J Lab Clin Med 121:424, 1993.
28. Mohri H, Fujimura Y, Shima M, Yoshioka A, Houghten RA, Ruggeri M, Zimmerman TS: Structure of the von Willebrand factor domain interacting with glycoprotein Ib. J Biol Chem 263:17901, 1988.
29. Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews R: Identification of aspartic acid-514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor-mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 31:11144, 1992.